Home ReVision Therapeutics

ReVision Therapeutics

In operation
-
Developer of Age-Related Macular Degeneration Drugs
Basic
Enterprise Profile
LinkedIn

Basic Information

ReVision Therapeutics Inc. is a company developing drugs for the treatment of age-related macular degeneration. Its products include (Fenretinide), an oral medication that can reduce the accumulation of A2E in the retina and slow the growth of atrophic lesions before vision loss.
ReVision Therapeutics Inc.
SanDiego,California,United States of America
less than 15 people
January 01, 2010
--

Enterprise Profile

Industrial Sector
New Drug Development
Concept
Ophthalmology Dermatology Department
Application Scenarios
Drug Concepts